Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026 and Aug 2026.
- Largest single sale: $3.8M (119,852 shares) of Eton Pharmaceuticals, Inc. on May 28, 2026. Filing
- Last sale before this period: Jun 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | President & CEO, Director | Nov 13, 2018 | Aug 20, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 20, 2026, Eton Pharmaceuticals, Inc.: sold 91,022 shares for $5.5M, no plan disclosed. 1 filing: 1
- Aug 19, 2026, Eton Pharmaceuticals, Inc.: sold 8,978 shares for $562K, no plan disclosed. 1 filing: 1
- Jul 31, 2026, Eton Pharmaceuticals, Inc.: 128,985 shares awarded. 1 filing: 1
- Jul 14, 2026, Eton Pharmaceuticals, Inc.: 200,000 shares acquired by exercising options. 1 filing: 1
- Jul 12, 2026, Eton Pharmaceuticals, Inc.: 27,500 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.